Chronische Rückenschmerzen

Chronische Rückenschmerzen gehören zu den häufigsten Erkrankungen in Deutschland. Vielfach findet sich keine morphologisch fassbare Veränderung, sodass die Genese bei über 90% der Patienten unspezifisch bleibt. Der vorliegende Artikel soll eine Übersicht über die medikamentöse Therapie wie auch die nicht-medikamentösen Maßnahmen geben und fasst die entsprechenden Leitlinienempfehlungen zusammen.

Abstract

Chronic back pain is one of the most common diseases in Germany. In many cases, no morphological change is found, so that the genesis remains unspecific in over 90% of patients. This article is intended to provide an overview of drug therapy as well as non-drug measures and summarizes the corresponding guideline recommendations.

Publikationsverlauf

Artikel online veröffentlicht:
18. Juli 2023

• Literatur

• 1 Balagué F, Mannion AF, Pellisé F. et al. Non-specific low back pain. Lancet 2012; 379: 482-491
• 2 Hoy D, March L, Brooks P. et al. The global burden of low back pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73: 968-974
• 3 Wenig CM, Schmidt CO, Kohlmann T. et al. Costs of back pain in Germany. Eur J Pain 2009; 13: 280-286
• 4 Dutmer AL, Schiphorst Preuper HR, Soer R. et al. Personal and societal impact of low back pain: the Groningen spine cohort. Spine 2019; 44: E1443-E1451
• 5 Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001; 344: 363-370
• 6 Foster NE, Anema JR, Cherkin D. et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 2018; 391: 2368-2383
• 7 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie nicht-spezifischer Kreuzschmerz – Langfassung. 2.Auflage. Version 1. 2017 https://www.leitlinien.de/themen/kreuzschmerz/2-auflage
• 8 de Schepper EI, Damen J, van Meurs JB. et al. The association between lumbar disc degeneration and low back pain: the influence of age, gender, and individual radiographic. Spine (Phila Pa 1976 2010; 35: 531-536
• 9 Cheung KM, Karppinen J, Chan D. et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 2009; 34: 934-940
• 10 Endean A, Palmer KT, Coggon D. Potential of magnetic resonance imaging findings to refine case definition for mechanical low back pain in epidemiological studies: a systematic review. Spine (Phila Pa 1976) 2011; 36: 160-169
• 11 Hopayian K, Song F, Riera R. et al. The clinical features of the piriformis syndrome: a systematic review. Eur Spine J 2010; 19: 2095-2109
• 12 Park JW, Lee YK, Lee YJ. et al. Deep gluteal syndrome as a cause of posterior hip pain and sciatica-like pain. Bone Joint J 2020; 102-B: 556-567
• 13 Shiri R, Karppinen J, Leino-Arjas P. et al. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 2010; 171: 135-154
• 14 Shiri R, Karppinen J, Leino-Arjas P. et al. The association between smoking and low back pain: a meta-analysis. Am J Med 2010; 123: 87 e7-35
• 15 Kalichman L, Hunter DJ. The genetics of intervertebral disc degeneration. Familial predisposition and heritability estimation. Joint Bone Spine 2008; 75: 383-387
• 16 Roffey DM, Wai EK, Bishop P. et al. Causal assessment of occupational sitting and low back pain: results of a systematic review. Spine J 2010; 10: 252-261
• 17 Swain CTV, Pan F, Owen PJ. et al. No consensus on causality of spine postures or physical exposure and low back pain: a systematic review of systematic reviews. J Biomech 2020; 102: 109312
• 18 Jegan NR, Brugger M, Viniol A. et al. Psychological risk and protective factors for disability in chronic low back pain – a longitudinal analysis in primary care. BMC Musculoskelet Disord 2017; 18: 114
• 19 Nickel FT, Seifert F, Lanz S. et al. Mechanisms of neuropathic pain. Eur Neuropsychopharmacol 2012; 22: 81-91
• 20 Kobayashi Y, Kurata J, Sekiguchi M. et al. Augmented cerebral activation by lumbar mechanical stimulus in chronic low back pain patients: an FMRI study. Spine (Phila Pa 1976) 2009; 34: 2431-2436
• 21 Mayr A, Jahn P, Stankewitz A. et al. Patients with chronic pain exhibit individually unique cortical signatures of pain encoding. Hum Brain Mapp 2022; 43: 1676-1693
• 22 Chou R, Qaseem A, Snow V. et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147: 478-491
• 23 Wurmthaler C, Gerbershagen HU, Dietz G. et al. Chronifizierung und psychologische Merkmale-Die Beziehung zwischen Chronifizierungsstadien bei Schmerz und psychophysischem Befinden, Behinderung und familiären Merkmalen. Z Gesundheitspsych 1996; 4: 113-136
• 24 Laine L, Curtis SP, Cryer B. et al. Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther 2010; 32: 1240-1248
• 25 Chang CH, Shau WY, Kuo CW. et al. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke 2010; 41: 1884-1890
• 26 Chaparro LE, Furlan AD, Deshpande A. et al. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev 2013; CD004959
• 27 Häuser W. 2. Aktualisierung der S3 Leitlinie „Langzeitanwendungen von Opioiden bei chronischen nicht-tumorbedingten Schmerzen „LONTS“. Schmerz 2020; 34: 204-244
• 28 Urquhart DM, Hoving JL, Assendelft WW. et al. Antidepressants for non-specific low back pain. Cochrane Database Syst Re 2008; CD001703
• 29 Skljarevski V, Ossanna M, Liu-Seifert H. et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009; 16: 1041-1048
• 30 Mazza M, Mazza O, Pazzaglia C. et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother 2010; 11: 1049-1052
• 31 Skljarevski V, Zhang S, Desaiah D. et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain 2010; 11: 1282-1290
• 32 Schukro RP, Oehmke MJ, Geroldinger A. et al. Efficacy of duloxetine in chronic low back pain with a neuropathic component: a randomized, double-blind, placebo-controlled crossover trial. Anesthesiology 2016; 124: 150-158
• 33 Romanò CL, Romanò D, Bonora C. et al. Pregabalin, celecoxib, and their combination for treatment of chronic lowback pain. J Orthop Traumatol 2009; 10: 185-191
• 34 Freynhagen R, Baron R, Gockel U. et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-1920
• 35 Liddle SD, Gracey JH, Baxter GD. Advice for the management of low back pain: a systematic review of randomised controlled trials. Man Ther 2007; 12: 310-327
• 36 Sakai Y, Ito K, Hida T. et al. Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration. Eur Spine J 2015; 24: 1309-1317
• 37 Engers A, Jellema P, Wensing M. et al. Individual patient education for low back pain. Cochrane Database Syst Rev 2008; 1: CD004057